Longevity · NAD+

NAD+ in the UAE — what the research says, what to buy

Wellness Labs Editorial·26 May 2026·9 min read

NAD+ has moved from biochemistry textbooks to pharmacy shelves in three years. The science is interesting; the marketing is louder. Here is a UAE-specific read on what the molecule actually does, what the supplement category looks like in Dubai today, and what an honest label should disclose.

What NAD+ actually is

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell of the human body. It exists in two paired states — NAD+ and NADH — and the cycling between them is the chemistry that powers most of your mitochondrial energy production. Beyond energy, NAD+ is a required substrate for two protein families that regulate aging biology in the laboratory: the sirtuins (which regulate stress response and metabolism) and the PARP enzymes (which repair DNA damage).

NAD+ levels measured in tissue samples decline with age across virtually every model organism studied — yeast, worms, flies, mice, and (in the smaller human studies that have been published) humans. That observation is real. The leap from “NAD+ declines with age” to “restoring NAD+ extends healthspan” is where the science is genuinely interesting and the marketing gets ahead of the data.

Why you cannot just take NAD+ directly

NAD+ is a charged molecule with very poor oral bioavailability. Swallowing pure NAD+ delivers almost nothing to the bloodstream — the gut breaks it down before it reaches systemic circulation. This is why the actual supplement category is NAD+ precursors: smaller molecules that the body can absorb and then convert into NAD+ intracellularly. The two precursors with the most human data are:

NMN (nicotinamide mononucleotide) — direct precursor, one enzymatic step from NAD+. Most-studied in animal models; growing human trials.
NR (nicotinamide riboside) — two enzymatic steps from NAD+. First to reach commercial scale (Chromadex’s Niagen, ~2014); has the largest published human safety dataset.

A third precursor, niacin (vitamin B3, also called nicotinic acid), is the classic NAD+ source from food and is GRAS-recognized worldwide. It works, but the flushing side-effect at therapeutic doses pushed the field toward NMN and NR — which raise NAD+ without the histamine release. Most “anti-aging NAD” products you see in the UAE are NMN or NR, sometimes blended with TMG (trimethylglycine) to support methylation.

What the human trials actually show (as of 2026)

The published human-trial literature on NMN and NR is small but converging. The pattern across roughly two dozen randomized controlled trials:

NAD+ levels in blood do rise with NMN/NR supplementation, dose-dependent, measurable within 2 weeks.
Safety profile is clean at the doses commercially marketed (250-1,000 mg/day for NMN; 300-500 mg/day for NR). No serious adverse events linked across the trials published to date.
Endpoints like grip strength, gait speed, and insulin sensitivity show modest improvements in some trials (notably the Yoshino group’s NMN work and several Chromadex-funded NR studies), null results in others.
Lifespan or healthspan extension in humans is not yet established — these trials run weeks to months, not decades.

Honest take: precursors raise NAD+. Whether that translates to the longevity benefits the marketing implies is the open question — and the trials that will answer it have not finished yet.

The UAE market in 2026

Walk into a Dubai longevity clinic and you’ll be offered intravenous NAD+ infusions — typically 500-1,000 mg over 2-4 hours, priced AED 800-2,500 per session. The clinical IV market is genuinely well-developed here; it bypasses the bioavailability problem and is what’s being sold in DIFC, Jumeirah, and the major medical centres.

The oral supplement market is thinner. The brands you’ll see in UAE pharmacies and the limited number of UAE-licensed online retailers include Charava MENA, a small number of international brands distributed through DXBStore or grocery imports, and the major US brands (Tru Niagen, ProHealth) that ship in via parallel import. Quality varies widely — third-party assay data is not standard, doses are often not clearly stated in mg of active ingredient, and “proprietary blend” labels are common.

IV vs oral — the practical question

Intravenous NAD+ delivers the molecule directly. Oral precursors raise systemic NAD+ via the salvage pathway over hours-days. The peak blood concentrations differ by an order of magnitude or more — IV is acute and dramatic, oral is steady-state and modest.

Which is better depends entirely on what you are actually trying to do. The published controlled-trial evidence for benefits sits on oral precursors. IV NAD+ has more anecdotal reports (energy, focus, recovery) and fewer rigorous trials. If your interest is in the longevity-research framing, oral NMN/NR is what the science has actually studied. If your interest is in subjective acute effects within a clinical setting, IV is what Dubai clinics offer.

Dosing in practice

The most-cited starting doses in the human-trial literature:

NMN — 250 mg/day for healthy adults, 500-1,000 mg/day in trials targeting metabolic or musculoskeletal endpoints. Most users start at 250 mg, raise after a month if tolerated.
NR — 300 mg/day is the most-studied dose; 500 mg/day in some Chromadex trials. Tolerability ceiling appears higher in NR than NMN at gram-level doses.
Stack add-ons — TMG (500-1,000 mg/day) is often co-supplemented to support methylation since NAD+ precursors can deplete methyl-donor pools at higher doses.

Who should not take NAD+ precursors

Pregnancy, breastfeeding, and active cancer treatment are the three categories where the safety data is insufficient — discuss with the treating clinician before starting. NMN in particular has theoretical interactions with the sirtuin signalling that influences tumour biology; the practical risk in supplementation doses is unclear, but the conservative default is to not add it during active oncology care.

Outside those three categories, the supplement-dose human-trial safety record is strong. The most common reported side effects are mild GI discomfort and (with niacin specifically) flushing.

How to evaluate a UAE-distributed brand

Three checks before you buy:

The brand publishes a third-party HPLC certificate for the lot you’re buying. Not a generic “we test” claim — an actual document with batch number.
The active ingredient is named in mg per serving on the supplement-facts panel. If the label says “NAD-complex 500 mg” without breaking down NMN vs filler, that’s a red flag.
The retailer has a UAE-registered entity for warranty and refund — not a dropship via Aliexpress or grey-market import.

Wellness Labs’ NAD+ research solution is one option in this category and is HPLC-verified per lot. We don’t claim it is the only honest option in the UAE market — we suggest using the three checks above whichever brand you settle on. The 100 mg research-consultation page covers the lot-specific analytical disclosure framework.